Article

NAACOS Submits Comments to CMS Regarding International Pricing Index Model

The National Association of Accountable Care Organizations (NAACOS) has submitted commented to CMS in response to the proposed International Pricing Index Model for Medicare Part B Drugs.

The National Association of Accountable Care Organizations (NAACOS) has submitted commented to CMS in response to the proposed International Pricing Index Model for Medicare Part B Drugs. Writing to CMS Administrator Seema Verma, the association said they appreciate CMS' efforts to lower drug prices as Medicare Part B drug spending has increased approximately 10% each year since 2011.

However, they also write that the proposal includes a number of unanswered questions about how the proposed model affects ACOs, which must be addressed before moving forward. They include recommendations on how CMS can address Part B drug costs while working with the Medicare Shared Savings Program and other ACO programs. Read the full comments and recommendations.

Related Videos
Lalan Wilfong, MD
Dr Kimlin Tam Ashing
Mike Fazio, Navista, Cardinal Health
Dr Kimlin Tam Ashing
Andrew Kuykendall, MD, Moffitt Cancer Center
John Michael O'Brien, PharmD, MPH
Frederick L Locke, MD, Moffitt
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Erin Weber, MS
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo